|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.46 USD | -0.81% |
|
+7.39% | +41.19% |
| Dec. 03 | Pacira Biosciences reports inducement grants under Nasdaq Listing Rule | RE |
| Dec. 02 | Pacira Says Iovera Outperformed Radiofrequency Ablation in Chronic Low Back Pain | MT |
EPS & Dividend: Pacira BioSciences, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 3.33 | 0.92 | 0.34 | 0.89 | -2.15 | 0.57 | 1.735 | 2.53 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 59.84 | 60.17 | 38.61 | 33.74 | 18.84 | 26.68 | 26.68 | 26.68 |
| Nbr of stocks (in thousands) | 43,444 | 44,544 | 45,882 | 46,438 | 46,173 | 43,021 | - | - |
| Announcement Date | 2/25/21 | 2/24/22 | 2/28/23 | 2/29/24 | 2/27/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Pacira BioSciences, Inc.
| 2026-02-18 | Q4 2025 Earnings Release (Projected) |
| 2026-05-06 | Q1 2026 Earnings Release (Projected) |
| 2026-08-03 | Q2 2026 Earnings Release (Projected) |
| 2026-10-28 | Q3 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | - | - | 46.81x | 1.72x | 1.74x | |
| 0.55% | 0.62% | 46.44x | 34.97x | 15.35x | |
| 2.41% | 2.49% | 20.48x | 6.52x | 5.68x | |
| 2.87% | 2.99% | 52.06x | 3103x | 7.52x | |
| 3.07% | 3.13% | 18.68x | 6.67x | 4.69x | |
| 1.77% | 1.87% | 27.43x | 6.19x | 5.19x | |
| 3.03% | 3.16% | 18.61x | 5.83x | 5.02x | |
| 3.23% | 3.27% | 12.96x | 4.66x | 4.23x | |
| 3.68% | 3.61% | 13.72x | 7.45x | 4.91x | |
| 2.94% | 3.11% | 25.64x | 19.38x | 6.05x | |
| Average | 2.62% | 2.69% | 28.28x | 319.64x | 6.04x | |
| Weighted average by Cap. | 2.18% | 2.25% | 31.00x | 380.81x | 8.27x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
